Dr. Reddy's Laboratories Ltd Common Stock vs Rigetti Computing Inc — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B), while Rigetti Computing Inc trades at $11.36 (market cap $3.90B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.7× Rigetti Computing Inc's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Rigetti Computing Inc for 36 Days on average.
| RDY | RGTI | |
|---|---|---|
Market Cap | $10.61B | $3.90B |
Volume | 3,738,869 | 25,246,719 |
Sector | Health | Technology |
52-Week High | $15.38 | $56.34 |
52-Week Low | $11.38 | $11.68 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $10.51B | $3.51B |
Dividend Yield | 0.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rigetti Computing (RGTI) trades at $12.78, down 3.55% today, with bearish technical signals but strong analyst support. The company shows minimal revenue of $7.09M (2025) with significant losses (-$216.21M net income), though recent quarters show mixed earnings performance. Positive sentiment stems from quantum computing sector momentum and strategic partnerships with HPE and PSC.
Outlook: High-risk, high-reward speculative play on quantum computing adoption. Analyst consensus price target of $21.67 offers ~70% upside, but persistent losses, negative cash flow, and intense competition pose substantial risks. Investment hinges on commercial scaling and technology execution amid cash burn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →